Category: Health

  • Dr Ravul Jindal Empowers SAARC Doctors with Expertise in Vascular Surgery in Sri Lanka

    Dr Ravul Jindal Empowers SAARC Doctors with Expertise in Vascular Surgery in Sri Lanka

    Dr Ravul Jindal

    Colombo [Sri Lanka], June 16: Dr Ravul Jindal, a globally renowned vascular surgeon, recently made significant contributions to the field of vascular surgery during his visit to Sri Lanka. His presentations on venous malformations, evaluation and treatment, as well as the latest advancements in managing varicose veins, garnered great attention at a conference attended by over a hundred doctors from the South Asian Association for Regional Cooperation (SAARC) countries. The meeting resulted in the establishment of the SAARC Society of Vascular Surgery, with Dr Jindal assuming the role of co-founder alongside esteemed colleagues from Sri Lanka, Bangladesh, Nepal, and India.

    During the meeting, Dr Ravul Jindal’s expertise in vascular surgery was showcased through his lectures and live demonstrations. He conducted a comprehensive workshop on the laser treatment of varicose veins, which was attended by 30 vascular surgeons from Sri Lanka. Prior to the procedure, Dr Jindal delivered a detailed one-hour lecture on the techniques and intricacies involved in laser treatment. The live demonstrations included ultrasound evaluation of varicose veins, tumescent anaesthetic techniques, and laser ablation performed under local anaesthesia. These hands-on sessions equipped the attending surgeons with valuable knowledge and practical skills.

    Working alongside accomplished professionals in the field, such as Dr Malenda (Sri Lanka), who assumed the presidency, Dr Shantanu Ghosh (Bangladesh), Dr Sandeep Pandey (Nepal), and Dr Shri Kumar (India), Dr Jindal’s co-founder status is a testament to his invaluable contributions and expertise in the field of vascular surgery.

    Dr Ravul Jindal’s visit to Sri Lanka and his presentations on venous malformations and the latest treatments for varicose veins were instrumental in advancing the field of vascular surgery within the SAARC region. The formation of the SAARC Society of Vascular Surgery serves as a platform for collaboration, knowledge sharing, and the promotion of best practices among vascular surgeons. Dr Jindal’s live workshop provided an opportunity for surgeons to enhance their skills through hands-on training. His commitment to elevating the field of vascular surgery and his invaluable contributions to the SAARC Society will undoubtedly lead to improved patient outcomes and the advancement of vascular healthcare in the region.

    If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

  • Digital Marketer Sociomark Bags Digital Mandate for Ayu Health

    Digital Marketer Sociomark Bags Digital Mandate for Ayu Health

    Sociomark Ayu Health

    Mumbai (Maharashtra) [India], June 15: Sociomark, a Mumbai-based digital marketing agency, proudly announces its recent triumph in securing the digital mandate for Ayu Health, the largest & most trusted healthcare brand in India. Following an extensive agency selection process that involved multiple pitches, Sociomark emerged as the ideal partner to bolster Ayu Health’s digital footprint.

    With a commitment to delivering innovative and results-driven digital marketing solutions, Sociomark has carved a niche in the industry. The agency’s expertise in leveraging cutting-edge technologies and comprehensive understanding of the digital landscape played a pivotal role in Ayu Health’s decision to entrust them with its digital mandate.

    Commenting on this partnership, Heta Desai Baandal, Managing Director of Sociomark, expressed her enthusiasm, stating, “We are thrilled to have been chosen as Ayu Health’s digital marketing partner. Our team is dedicated to delivering exceptional results by employing strategic digital solutions tailored to Ayu Health’s unique requirements. We are confident that this collaboration will strengthen Ayu Health’s online presence and drive significant growth.”

    Ayu Health, renowned for its commitment to providing holistic healthcare solutions, recognized the need for a digital marketing partner that could help them reach a wider audience and enhance brand visibility across various online platforms. By partnering with Sociomark, Ayu Health aims to amplify its brand messaging and establish a stronger connection with its target market.

    “Himesh Joshi, Founder & CEO of Ayu Health, stated, “We are excited to embark on this journey with Sociomark. Their impressive track record and strategic approach align perfectly with our vision for digital expansion. Together, we aim to create a powerful online presence, engage with our customers more effectively, and reinforce Ayu Health’s position as a leader in the healthcare industry.”

    About Sociomark: Sociomark is an award-winning Mumbai-based digital marketing agency specializing in delivering innovative and impactful digital marketing solutions. With a team of seasoned professionals and a customer-centric approach, Sociomark helps businesses achieve their digital goals, boost brand visibility, and drive significant growth.

    About Ayu Health: Ayu Health is a trusted healthcare brand with 140+ high-quality hospitals across India. Ayu Health makes top-notch healthcare accessible, focusing on innovation, quality, and affordability. An unmatched Google rating of 4.7 proves Ayu Health’s commitment to customer satisfaction.

  • Unveiling the Power of Personalized Nutrition: LabEasy’s Advanced Food Sensitivity (IgG Food Intolerance) and Allergy Test

    Unveiling the Power of Personalized Nutrition: LabEasy’s Advanced Food Sensitivity (IgG Food Intolerance) and Allergy Test

    Introduction:

    In recent years, there has been a growing awareness of the impact that certain foods can have on our overall health and well-being. Food sensitivities and allergies have become increasingly common, leading many individuals to seek answers and solutions to their dietary concerns. LabEasy, a leading provider of advanced diagnostic testing, offers a comprehensive approach to food sensitivity (IgG Food Intolerance) and allergy testing, empowering individuals to make informed decisions about their diet and health.

    Understanding Food Sensitivities (IgG Food Intolerances) and Allergies:

    Food sensitivities and allergies are adverse reactions to certain types of food. While they may exhibit similar symptoms, there are distinct differences between the two. Food allergies involve an immune response triggered by specific proteins present in the food, leading to immediate reactions that can range from mild to life-threatening, such as anaphylaxis. Food sensitivities, on the other hand, often result in delayed and more subtle symptoms that can be challenging to identify.

    The Importance of Accurate Testing:

    Accurate testing is crucial when it comes to identifying food sensitivities and allergies. Many individuals resort to elimination diets or self-diagnosis, which can be time-consuming, inconvenient, and may not provide accurate results. LabEasy recognizes the need for reliable testing methods that can accurately identify problematic foods, helping individuals make informed decisions about their dietary choices.

    LabEasy’s Comprehensive Testing Approach:

    LabEasy takes a holistic and evidence-based approach to food sensitivity (IgG Food Intolerance) and allergy testing. They offer a range of advanced diagnostic tests designed to identify specific food triggers, empowering individuals to personalize their diets and optimize their health.

    1. IgE Allergy Testing: LabEasy utilizes immunoglobulin E (IgE) antibody testing to identify immediate allergic reactions. This type of testing is crucial for diagnosing potentially life-threatening allergies and determining the appropriate management strategies.
    2. IgG Food Sensitivity (IgG Food Intolerance) Testing: LabEasy offers IgG antibody testing to detect delayed immune reactions, which are associated with food sensitivities. By identifying IgG antibodies specific to certain foods, individuals can make informed decisions about their diet and potentially alleviate symptoms.
    3. Nutritional Guidance: LabEasy understands that accurate testing is just the beginning. They provide comprehensive nutritional guidance based on test results, helping individuals develop personalized dietary plans that meet their nutritional needs while avoiding problem foods.
    4. Professional Support: LabEasy’s Food Sensitivity (IgG Food Intolerance) and Allergy Test comes with the added benefit of expert support. A team of qualified healthcare professionals is available to guide individuals through their test results, offering personalized recommendations and answering any questions that may arise.

    Benefits of Choosing LabEasy:

    By choosing LabEasy for food sensitivity (IgG Food Intolerance) and allergy testing, individuals can benefit from:

    1. a) Accurate and reliable testing methods that provide a clear understanding of their dietary concerns.
    2. b) Personalized guidance on food choices and nutritional support to optimize health outcomes.
    3. c) Convenient sample collection options: either from the comfort of one’s own home or at a LabEasy-affiliated diagnostic center.
    4. d) Access to a team of qualified healthcare professionals who are dedicated to helping individuals on their wellness journey.

    About LabEasy:

    LabEasy is at the forefront of food sensitivity (IgG Food Intolerance) and allergy testing, offering a comprehensive approach to identifying problematic foods and empowering individuals to make informed decisions about their diet. By utilizing advanced diagnostic tests and providing personalized nutritional guidance, LabEasy enables individuals to take control of their health and improve their overall well-being. If you are experiencing dietary concerns, LabEasy is here to support you on your journey towards a healthier and happier life.

    If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

  • Non-Surgical, Next Generation Cryoablation Technology- A Boon for Cancer Patients

    Non-Surgical, Next Generation Cryoablation Technology- A Boon for Cancer Patients

    Mumbai (Maharashtra) [India], June 9: Cancer patients in India can now heave a sigh of relief, thanks to the availability of cryoablation technology in the country. Cryoablation is a minimally invasive image-guided (ultrasound or CT scan) treatment that uses extreme cold to freeze and accurately destroy diseased tissue within the tumour zone.  This technology is the brainchild of an Israeli company, IceCure Medical. Its flagship product, Pro-Sense, freezes tumours quickly and with minimal pain. It uses liquid nitrogen (LN2) for maximum freezing, safety, and efficacy. NovoMed Incorporation Pvt  Ltd is the authorized distributor of  IceCure Medical in India.

    During cryoablation, a thin, needle-like probe called a cryoprobe is inserted into the target area. The cryoprobe uses liquid nitrogen as a coolant, which rapidly cools the surrounding tissue. As the tissue freezes, ice crystals form, causing cellular damage and destruction. Extreme cold temperatures essentially freeze and kill abnormal cells.

    Cryoablation has several advantages over other treatment methods. It is considered a minimally invasive procedure, meaning it requires only a small incision or needle puncture, resulting in less trauma to the body and faster recovery times compared to open surgery. It can be performed under local anaesthesia, eliminating the need for general anaesthesia in many cases. Additionally, cryoablation is relatively precise, allowing for targeted treatment of the abnormal tissue while preserving surrounding healthy tissue. A hospital stay is not required in most cases.

    The specific application of cryoablation depends on the condition being treated. It is commonly used in the treatment of benign and malignant tumours of various kinds, including breast cancer, kidney cancer, liver cancer, lung cancer, bone, soft tissue, and other types of tumours.

    Dr.Bhavin JankhariaConsultant Radiologist, observed,” My experience of using the IceCure machine has been excellent. Not only are the results good, but we also have great support from Jay and Prashant and their team, which makes our life and the patient’s life much easier when the cryoablation is being done. We also have terrific support from the Israeli team, specially Snir and Tlalit.  Cryoablation fills a niche in the overall ablation space. While RF (Radio Frequency) ablation has been around in clinical practice for more than 20 years now in India and microwave has slowly established itself in the last 5 years, cryoablation has been a slow mover. It is probably the best technique for fibromatosis and specific bone and soft tissue tumours and for renal tumours. In the lung and liver, it has to compete with RFA and microwave, both of which are equally good.”

    Dr Vimal SomeshwarInterventional Radiologist at Kokilaben Dhirubai Ambani Hospital and Medical Research Institute, opined,” In my personal experience, the results have been very good, and cryoablation is also excellent for pain management. This technology has tremendous potential and may have far wider applications in the future.”

    The cryoablation therapy was also recently introduced at the Kovai Medical Center in Coimbatore. Jay MehtaDirectorSalesNovoMed Incorporation Pvt Ltd, stated, “We are indeed very happy to facilitate the availability of this futuristic and revolutionary technology in India.  The Indian populace should take maximum advantage of the same and freeze cancer in its tracks.”

    If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

  • India’s first wearable device, Migraelief to treat migraine headaches and mental health problems

    India’s first wearable device, Migraelief to treat migraine headaches and mental health problems

    Jaideep Tiwari and K. Kartik

    Migraelief is a wearable device that relieves migraine and mental health problems without any side effects or medications. Jaideep Tiwari dealing with anxiety disorders, introduced this innovation! 

    New Delhi (India), June 9: Anxiety disorders are real. People may suggest meditations, medications or many solutions to control them. However, it’s not that simple, and anxiety can cause several health issues, which can lead to migraine, insomnia, eating disorders, weight gain or weight loss and many more. Some people may get addicted to alcohol or start consuming drugs like painkillers and tranquilisers. But these are for instant and temporary relief only, which may come with a lot of side effects on your body. So, the young entrepreneurs and founders of Brahmansh from Bhilai named, Jaideep Tiwari and K Kartik introduced an amazing innovation named Migraelief that will relieve stress and anxiety disorders without any kind of side effects on your body.

    “Migraelief” is the first wearable migraine treatment in INDIA. Various studies have shown that more than 700 million people experience sleep problems, migraine, and stress worldwide. However, drugs are only for immediate comfort, which is why this innovation has been introduced, and it’s bringing a revolution in the tech industry on the day of its launch itself.

    Migraelief is revolutionising how we treat sleep difficulties, migraine headache pain, and stress without the need for drugs. The unique quality of Migraelief is its capacity to relax the nervous system and quiet it down after just 20 minutes of use. Migraelief effectively relieves the frazzled nerves that frequently accompany headaches, offering a pleasant break from the pounding sensations in the head that accompany a migraine. Additionally, Migraelief promotes sound sleep in addition to treating headaches. Users of Migraelief can quickly fall asleep because of its special, patented technology that aids in achieving the ideal brain state for deep sleep.

    Talking about how this idea came into the founders’ mind that Jaideep and Kartik both studied engineering at SSGI Bhilai (C.G), a small town in Chhattisgarh. Since their college days, they have collaborated and worked on numerous projects together. However, in 2015, Jaideep was diagnosed with anxiety disorder and required treatment. Turning the weakness into strength, the duo decided to explore the potential of technology to create a product that addresses the problem of mental health. In 2017, they began their research to create a technology that uses sound waves as a method of stimulation to calm down the nervous system. So, after lots of research and hard work, they developed this amazing technology and received the patent name in the year 2020. Now, their innovation is named Migraelief.

    Talking about their business, Brahmansh Technologies Pvt. Ltd. Company is the brainchild of Jaideep Tiwari and K. Kartik and was founded in the year 2018. These college students from Bhilai, Chhattisgarh, were selected for a national event named “Smart India Hardware Hackathon”. And after becoming the winner of this national level event, mentors named Deepak Bhopatkar (ISRO retired scientist) and Sudarshan Natu (ex-vice president of HARMAN)  invited them from Bhilai to Pune after seeing their innovative ideas and work. The support of mentors kick-started their entrepreneurial journey. Not only this, but with the guidance and support of the mentors, they also received grants from prestigious institutes like IIT BOMBAY, IIT DELHI, IIM Calcutta, and many other Govt. bodies like DST and BIRAC.

    Recently their company was selected among the top 10 startups to represent medical device startups of INDIA in FRANCE. Now, people can come and try this device at many healthcare centres in Bengaluru. Doctors are also appreciating and accepting these entrepreneurs’ innovations for the treatment of their patients.

    Both Jaideep and Kartik are on the run to innovate and explore the tech world with their creative ideas. The devices founded by them are the most affordable and best in terms of use as compared to the other devices available in the market. It’s easy to use, portable, cost-effective and gives the best results. Now they are all set to experiment with the ideas and bring more such innovation into the tech world!

    Website link- https://bramhansh.com

    If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

    The post India’s first wearable device, Migraelief to treat migraine headaches and mental health problems first appeared on PNN Digital.

  • MasMedi: Redefining Healthcare Solutions with Transparency, Accessibility and Customer-First Approach

    MasMedi: Redefining Healthcare Solutions with Transparency, Accessibility and Customer-First Approach

    Mumbai (Maharashtra) [India], June 7: MasMedi, a one-of-its-kind tech-driven healthcare aggregator app and marketplace for Diagnostic Labs and Ambulance services is transforming the healthcare space by providing freedom of lab selection and affordable solutions to its customers.

    Using cutting-edge technology, MasMedi is placing the power in the hands of its customers by proving options to choose from nearby local and hyperlocal Diagnostic Labs (Pathology & Radiology) and Ambulance services, enabling them to make informed decisions without hassles and any hidden charges. Additionally, it is also empowering local labs and service providers through its policy of complete transparency and unbiased diagnostic needs.

    With a vast network of over 450 accredited labs across Mumbai, Thane, and Navi Mumbai, including prestigious accreditations such as NABL and CAP, MasMedi ensures that customers have access to trusted and reliable diagnostic services. Using its user-friendly interface, the application enables users to conveniently search for tests, locate nearby labs, hassle-free Instant bookings and add prescriptions. Users can also avail of benefits such as complimentary doctor consultations and second opinions. Another unique feature of this unique platform is the option to compare labs for any given test with complete transparency on parameters like rating, distance, rates and reviews. Users can also get their test reports on the platform itself.

    “We realized that accessibility of basic health checkup solutions is a challenge. We created this tech-enabled platform to bridge this gap and make health checkups affordable and also accessible. The tech-powered platform empowers users to choose from the vast number of best diagnostics labs close to them in the most transparent manner, helping both users and service providers. Our platform has already helped thousands of users, and we believe it has the potential to revolutionize the healthcare industry by enabling comprehensive services without crazy pricing, which is in sync with our customer-first strategy and commitment,” said Rajib Banerjee, Founder & CEO of MasMedi.

    MasMedi’s Unmatched features, Unbiased advice and excellent services have garnered immense praise from its ever-growing customer base. It has catered to more than 6,000 satisfied customers to date. In addition to the best pricing, the platform’s tie-ups with a vast network of accredited labs across Mumbai, Thane, and Navi Mumbai also ensure the best discounts and package deals for customers, making it a trusted name in the healthcare space.

    For more information, kindly visit the website https://www.masmedi.com/ or download the MasMedi app from Google or Apple app store.

    If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

    The post MasMedi: Redefining Healthcare Solutions with Transparency, Accessibility and Customer-First Approach first appeared on PNN Digital.

  • Signia Celebrates 25 Years of Pioneering Innovation and Transforming Lives in India

    Signia Celebrates 25 Years of Pioneering Innovation and Transforming Lives in India

    Bengaluru (Karnataka) [India), June 6: Signia, a leader in the hearing aid industry, is celebrating 25 years of driving innovation, improving hearing health, and transforming lives across India. Part of the globally recognized WSA Group, Signia marks this tremendous milestone with a track record of making hearing impairment less of a challenge and more of an empowering journey.

    For 25 years, Signia has been at the forefront of revolutionizing hearing aid technology in India, never ceasing to amaze. The ‘Brilliant Sound Galaxy (BSG)’ concept stores, introduced across multiple cities, have proven to be a game-changer. Providing a unique interactive platform for people to self-discover, self-screen, and indulge in a live hearing experience, Signia has transformed the path of auditory enhancement.

    Elated about this landmark achievement, Mr. Avinash Pawar, CEO & Managing Director, Sivantos India Pvt. Ltd., expressed, “Our 25-year journey has been incredible and rewarding. We’ve grown, innovated, and, most importantly, we’ve made a real difference in the lives of thousands. The future holds even more promise as we continue to break barriers and empower individuals in their auditory journey.”

    Signia’s heart beats not just for innovation but also for giving back to society. The company has, over the years, gifted many hearing aids to the underprivileged, aiding their progress into a world of sound. Adding to this endeavour, Signia has proudly taken under its wing the prodigious Shourya Saini, a deaf sports shooter who has amazed the world with his performance and resilience.

    The pride of India’s music industry and the brand ambassador for Signia, the legendary Sudesh Bhosle, lauded this journey, “As someone who owes his life to sounds, I stand in awe of Signia’s unwavering commitment to break down auditory barriers. It is a matter of great pride to join hands with an organization that is as passionate about sound as I am. On this momentous occasion, here’s to creating more melodies, spinning more tales, and touching more lives.”

    Signia’s journey of 25 years is a testament to its relentless passion for sound. As it steps into the next era, it promises to keep its symphony alive – of innovating, of helping people hear the world in all its brilliance, and of giving sound to silent stories.

    Hear.com

    Hear.com is a WSA group company that specializes in digital marketing and provides hearing consultations, and connects people with a hearing care professional. The company has experts that assist a person throughout every step of the process of ordering hearing aids.

    Sivantos India Private Limited: 

    Sivantos India Pvt. Ltd. is a part of the WSA Group, which is one of the world’s top manufacturers of hearing aids. In fact, the company develops and manufactures one out of every three hearing aids being used worldwide. Sivantos provides hearing care professionals with hearing aids branded Signia, Audio Service, Rexton and A&M. Complementary accessories, fitting software, smartphone apps and diagnostic workflow solutions are also part of the company’s portfolio.

    If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

    The post Signia Celebrates 25 Years of Pioneering Innovation and Transforming Lives in India first appeared on PNN Digital.

  • Eyestem files for IND approval for its product to treat geographic atrophy, the largest cause of incurable blindness in the world for people over 50

    Eyestem files for IND approval for its product to treat geographic atrophy, the largest cause of incurable blindness in the world for people over 50

    Bengaluru (Karnataka) [India], June 5: Dry age-related macular degeneration (dry AMD) is the largest cause of incurable blindness in the world for patients over 50 years. 170 million people suffer from this disease around the world, 25 million of which are in India. These numbers will, unfortunately, increase in the coming decades as our population ages. The more severe version of dry AMD is geographic atrophy, and no therapy is available to arrest or reverse this loss of vision.

    Eyestem Research today announced the submission of an Investigational New Drug (IND) application to the Central Drugs Standards Control Organization, India (CDSCO) to begin first-in-human trials of Eyecyte-RPEfor subjects with medium- and late-stage geographic atrophy, secondary to dry AMD.

    Dr. Rajani Battu, Chief Medical Officer of Eyestem Research, said, “We are excited to start human trials for Eyecyte-RPE. Dry AMD is a huge disease burden, and this therapy has the potential to make a meaningful difference in our patient’s lives.”

    Dr. Jogin Desai, Chief Executive Officer of Eyestem Research, said, “Most cell and gene therapy products under development in the West are estimated to cost over US$ 200,000.Our vision is to democratize access to such treatments at a fraction of these costs and begin disruption of the current status quo with our Eyecyte-RPE product.”

    Eyestem Research is a deep science company incubated at the Centre for Cellular and Molecular Platforms, Bangalore, and supported by DBT-BIRAC as well as prestigious Indian and global healthcare investors. The IND submission for Eyecyte-RPEis supported by robust GLP toxicology data from Dabur Research Foundation in India and excellent efficacy/safety data in animal models at Oregon Health and Science University. Validation of the injection technique and dose-finding studies were done in advanced animal models at the Singapore Eye Research Institute.

    About Eyecyte-RPE

    Eyecyte-RPE™ is a patented suspension of iPSC-derived fate-committed retinal pigment epithelium cells, which are highly potent, safe, and efficacious in in-vitro and in-vivo studies. The cells are derived from induced pluripotent stem cells, are allogeneic in nature, and can be stored for long periods of time.

    If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

    The post Eyestem files for IND approval for its product to treat geographic atrophy, the largest cause of incurable blindness in the world for people over 50 first appeared on PNN Digital.

  • Kindness Practice Foundation conducted free cancer awareness camp at Mumbai

    Kindness Practice Foundation NGO free cancer awareness camp at Mumbai

    Mumbai (Maharashtra) [India], June 5: Keeping in view the rapid rise of the number of cancer cases in India, Kindness Practice Foundation, a Section 8 NGO in the space of preventive and mental health, organised a free Cancer Awareness Camp to spread clinically evidenced information as well as free diagnostics cancer screening to those who attended. “Cancer does not discriminate on the basis of gender, ethnicity, race or health status,” explained Dr Rachna Chhachhi, Founder of Kindness Practice Foundation. “Early detection can lead to more positive outcomes,” she said. Rachna is an Integrative Cancer, Nutrition and Mental Health Expert and has been treating cancer patients across 27 countries for 15 years.

    Free screening for cancer was provided by Healthians, a diagnostic lab with 250+ labs across the country. “We are seeing the heartbreaking impact of breast cancer for the last 10 years, in Tier 2, Tier 3 cities and the rural areas,” shared Deepak Sahni, Founder & CEO, Healthians.  “Our aim is to focus not only on the illness but also emphasize the urgent need for early diagnosis via our next-gen technology and preventive healthcare.” Breast, lung and colorectal cancers are the largest number of cancer cases prevalent.

    The camp was attended by cancer patients and those who came out in support to spread positivity and hope. Many of the speakers were cancer patients themselves. Even though the camp was held in Mumbai, people also joined online from across the country, where the NGO has on-boarded recovered cancer patients as volunteer workers to spread awareness about cancer. “In February 2021, I was diagnosed with late-stage ovarian cancer,” shared Rinku Agrawal, who heads the Patna division on cancer awareness for Kindness Practice Foundation. “I diligently went through my medical treatments but with severe side effects. I simultaneously went through integrative cancer treatment with Rachna Chhachhi, and this combined approach healed me. Today when my relatives and friends see me, they cannot believe that I ever had cancer.” Rinku is spreading awareness about cancer for the foundation in Bihar. In the same manner, the foundation has Dipali Theckedath, a two-time cancer survivor for the Mumbai chapter, Bhavna Sreshth, an ovarian cancer survivor who heads Maharashtra and Sonali Gupta, a Leiomyosarcoma cancer warrior for the Delhi chapter.

    The bravest of all those who attended was Jasmine Gulati from Patiala, Punjab, who lost her six-year-old son to cancer and decided to dedicate her life to creating cancer awareness for young mothers. “I’m a mother who has lost her firstborn to cancer. No mother deserves to go through that. That’s why I’m here to support the cause of cancer awareness so that we can help our kids live. My son has given me this courage,” she shared at the camp. “A child with cancer is the biggest example of courage and hope. Cancer is there. We have to accept it. Early detection and prevention is the key. Never ignore early signs that your body sends to you,” she implored as she spoke to young mothers.

    Cancer cases are rising because people under chronic stress may develop certain unhealthy behaviours, such as smoking, overeating, becoming less active, or drinking alcohol. These habits are associated with increased risks of lifestyle cancers, which account for the majority of cancers. Approximately 1.5 million are grappling with cancer in India. And this is under-reported.  As per WHO, Cancer is a leading cause of death across the world, accounting for nearly 10 million deaths in 2020 or 1 in 6 deaths. Sadly, women are more prone to cancer than men. One-third of deaths from cancer are due to tobacco use, high body mass index (overweight), alcohol consumption, low fruit and vegetable intake, and lack of physical activity, all of which are avoidable. The camp raised awareness about all these and also gave a handout to everyone after the diagnostic screening for tips on prevention.

    If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

    The post Kindness Practice Foundation conducted free cancer awareness camp at Mumbai first appeared on PNN Digital.

  • Eyestem files for IND approval for its product to treat geographic atrophy, the largest cause of incurable blindness in the world for people over 50

    Eyestem files for IND approval for its product to treat geographic atrophy, the largest cause of incurable blindness in the world for people over 50

    Read Time:1 Minute, 58 Second

    Bengaluru (Karnataka) [India], June 5: Dry age-related macular degeneration (dry AMD) is the largest cause of incurable blindness in the world for patients over 50 years. 170 million people suffer from this disease around the world, 25 million of which are in India. These numbers will, unfortunately, increase in the coming decades as our population ages. The more severe version of dry AMD is geographic atrophy, and no therapy is available to arrest or reverse this loss of vision.

    Eyestem Research today announced the submission of an Investigational New Drug (IND) application to the Central Drugs Standards Control Organization, India (CDSCO) to begin first-in-human trials of Eyecyte-RPE™for subjects with medium- and late-stage geographic atrophy, secondary to dry AMD.

    Dr. Rajani Battu, Chief Medical Officer of Eyestem Research, said, “We are excited to start human trials for Eyecyte-RPE™. Dry AMD is a huge disease burden, and this therapy has the potential to make a meaningful difference in our patient’s lives.”

    Dr. Jogin Desai, Chief Executive Officer of Eyestem Research, said, “Most cell and gene therapy products under development in the West are estimated to cost over US$ 200,000.Our vision is to democratize access to such treatments at a fraction of these costs and begin disruption of the current status quo with our Eyecyte-RPE™ product.”

    Eyestem Research is a deep science company incubated at the Centre for Cellular and Molecular Platforms, Bangalore, and supported by DBT-BIRAC as well as prestigious Indian and global healthcare investors. The IND submission for Eyecyte-RPE™is supported by robust GLP toxicology data from Dabur Research Foundation in India and excellent efficacy/safety data in animal models at Oregon Health and Science University. Validation of the injection technique and dose-finding studies were done in advanced animal models at the Singapore Eye Research Institute.

    About Eyecyte-RPE™

    Eyecyte-RPE™ is a patented suspension of iPSC-derived fate-committed retinal pigment epithelium cells, which are highly potent, safe, and efficacious in in-vitro and in-vivo studies. The cells are derived from induced pluripotent stem cells, are allogeneic in nature, and can be stored for long periods of time.

    If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

    The post Eyestem files for IND approval for its product to treat geographic atrophy, the largest cause of incurable blindness in the world for people over 50 appeared first on Republic News Today.